Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sarpagandha,Khurasani Ajwain,Jatamansi
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Sarpagandha Ghan Vati to Treat High Blood Pressure!
Details : Sarpagandha Vati’s diuretic and detoxifying properties benefit people with lifestyle issues, epilepsy, delirium, anxiety disorder, curbs desire for alcohol and induces natural sleep to defy Insomnia.
Brand Name : Sarpagandha Ghan Vati
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 23, 2022
Lead Product(s) : Sarpagandha,Khurasani Ajwain,Jatamansi
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Artemisinin,Curcumin,Boswellia Serrata
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : MGC Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
HempStreet Announces Partnership with MGC Pharma to Revolutionise Global Phytomedicine Sector
Details : Through this partnership, and through HempStreet’s extensive distribution reach and key institutional partnerships, Indian patients will now have access to these medicines, starting with CimetrA (Artemisinin), which had an immediate need.
Brand Name : CimetrA
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 07, 2022
Lead Product(s) : Artemisinin,Curcumin,Boswellia Serrata
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : MGC Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?